Details of the Drug
General Information of Drug (ID: DMIHJSA)
Drug Name |
2-Bromoacetyl Group
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
BROMOACETIC ACID; 2-Bromoacetic acid; 79-08-3; Monobromoacetic acid; Bromoethanoic acid; Acetic acid, bromo-; To NTU; Bromoacetate ion; Acide bromacetique; 2-bromoethanoic acid; 2-Bromoacetyl Group; Monobromessigsaeure; Acetic acid, 2-bromo-; Bromo-acetic acid; Kyselina bromoctova; alpha-Bromoacetic acid; Caswell No. 112A; NSC 141; .alpha.-Bromoacetic acid; Acide bromacetique [French]; Kyselina bromoctova [Czech]; Monobromessigsaeure [German]; CCRIS 7886; UNII-2B3HS32431; Acetic acid, bromo-, (solution); alpha-Bromoethanoic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 138.95 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||